Your gateway to a free society
Article
The Hunger Margin: How Intel Analysts Learned To Measure The End Of Abundance
The Hunger Margin: How Intel Analysts Learned To Measure The End Of Abundance
Authored by Milan Adams via Preppgroup,
The shift happened gradually, then all at once.
By late 2024, analysts at Langley and Fort Meade who had spent careers tracking terrorist cells and nuclear programs found themselves redirected to spreadsheets showing fertilizer shipments, satellite passes over Ukrainian wheat fields, and soil moisture readings from the Sahel. Nobody had issued a memo announcing the change.
It simply became obvious that agricultural data had become national security data, and that the old distinctions...
aboutLiberty Portal
Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Jun 17, 2026 / Jason Ditz
Israel Continues to Pound Southern Lebanon as Hezbollah Drones Wound IDF Troops
At least two people were killed today as Israeli artillery continued to shell southern Lebanon, and reports were that Israeli ground troops advanced further north into Lebanese territory as the conflict continues to be a major stressor on the US-Iran peace deal. The number of Israeli strikes on Lebanon seemed to markedly decline on Monday, […]
Read more
Jul 21, 2026 / Dave DeCamp
US Intelligence Assessment Says the US Cannot Bomb Iran Into Capitulation
The Washington Post reported on Monday night that a new US intelligence assessment says that Iran’s government is unlikely to feel a significant impact or change its negotiating position as a result of the US airstrikes that have been hitting Iran. The report, which cited current and former US officials, said that US intelligence agencies […]
Read more
May 21, 2026 / Tyler Durden
Lilly's Next-Gen Weight-Loss Drug Clears Trial With Near-Bariatric Surgery Results
Lilly's Next-Gen Weight-Loss Drug Clears Trial With Near-Bariatric Surgery Results
Eli Lilly reported positive Phase 3 results for its next-generation obesity drug, retatrutide, which delivered weight-loss results on par with those of bariatric surgery.
In the TRIUMPH-1 trial, overweight adults, but without diabetes, achieved meaningful weight loss across all tested doses after 80 weeks:
12 mg dose: average weight loss of 70.3 pounds, or 28.3% of body weight.
9 mg dose: average weight loss of 64.4 pounds, or 25.9%.
4 mg dose: average weight loss of 47.2 pounds, or 19%
Ahead of the results,...
Read more
support
If you like what we do and want to support us, then you are a fine humanitarian. Click the link below to find out more.
Support the liberty movement
Want to get in touch?